SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-023871
Filing Date
2024-06-14
Accepted
2024-06-14 16:15:35
Documents
14
Period of Report
2024-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57636
2 ex99-1.htm EX-99.1 24583
  Complete submission text file 0001493152-24-023871.txt   270336

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vvos-20240614.xsd EX-101.SCH 3006
4 XBRL LABEL FILE vvos-20240614_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vvos-20240614_pre.xml EX-101.PRE 22353
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

IRS No.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 241044987
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)